Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
58 /100
HIGH RISK
Score updated Oct 13, 2026

XFOR — X4 Pharmaceuticals, Inc. Dilution Risk Tracker

Track XFOR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track XFOR — Get alerts when the score changes →

As of October 13, 2026, X4 Pharmaceuticals, Inc. (XFOR) has a DilutionWatch DilutionScore of 58/100, rated HIGH dilution risk. X4 Pharmaceuticals, Inc. has a market capitalization of $288.52M, 99.15M shares outstanding, 82 institutional holders tracked. Stored dilution-related fields include 37.92M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
25
📊 Float Risk
55
⚠️ Warrant Exposure
90
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 30%
📜 Warrant Exercise model 60%
• Massive warrant overhang: 38% of shares outstanding
• Warrant risk score very high (90/100)
🔔 Track XFOR — Get forecast alerts →

Market Data

Market Cap$288.52M
Shares Outstanding99.15M
Float57.41M
Cash$195.09M
Debt$54.57M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore58/100DilutionWatch score record
Shares Outstanding99.15MVerified float table or market cache
Public Float57.41MVerified float table or market cache
Market Cap$288.52MMarket data cache
Cash Runway18.1 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants37.92MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 34.0% shares (2026Q1 vs prior)
82 institutional holders · 115.29M shares
#1 MORGAN STANLEY 17.68M shares
#2 PERCEPTIVE ADVISORS LLC 13.48M shares
#3 Empery Asset Management, LP 8.94M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest7.59M
Days to Cover6.0
% of Float13.2%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-17
xbrl XBRL CONVERTIBLE 2022-03-17
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual XFOR Dilution Snapshot

X4 Pharmaceuticals, Inc. (XFOR) has a DilutionScore of 58/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

XFOR's DilutionScore is currently 58/100 (High risk), with 4 score changes tracked over 89 days. The score improved from 52/100 (High risk).

Period Score Risk Level Duration
Sep 30 – Oct 13, 202658/100HIGH14 days
Sep 13 – Sep 29, 202652/100HIGH17 days
Aug 22 – Sep 12, 202663/100HIGH22 days
Aug 14 – Aug 21, 202658/100HIGH7 days
Jul 16 – Aug 13, 202661/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

XFOR shares outstanding have increased 7.9% from 87.44M (Mar 2026) to 94.32M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 18, 202694.32M57.41M▼ 15.30%
May 17, 202694.32M67.78M▲ 1.21%
May 15, 202694.32M66.97M▲ 0.01%
May 10, 202694.32M66.97M▲ 3.74%
Apr 05, 202690.92M64.55M▼ 0.08%
Mar 23, 202690.92M64.61M▲ 1.65%
Mar 19, 202687.44M63.56M▲ 3.98%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track XFOR Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment XFOR files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking XFOR — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for XFOR
XFOR FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.